HomeBOT • ASX
add
Botanix Pharmaceuticals Ltd
Previous close
$0.049
Day range
$0.045 - $0.049
Year range
$0.045 - $0.49
Market cap
102.17M AUD
Avg Volume
14.08M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 8.25M | 4,271.29% |
Operating expense | 22.08M | 41.82% |
Net income | -16.60M | -7.47% |
Net profit margin | -201.11 | 97.54% |
Earnings per share | — | — |
EBITDA | -16.22M | -5.12% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.61M | -34.73% |
Total assets | 98.57M | -0.88% |
Total liabilities | 44.58M | 540.50% |
Total equity | 54.00M | — |
Shares outstanding | 1.97B | — |
Price to book | 1.63 | — |
Return on assets | -42.63% | — |
Return on capital | -76.30% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -16.60M | -7.47% |
Cash from operations | -15.14M | 0.95% |
Cash from investing | -220.81K | 48.29% |
Cash from financing | -1.28M | -738.08% |
Net change in cash | -16.68M | -8.04% |
Free cash flow | -7.24M | -58.36% |
About
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Founded
1984
Website
Employees
11
